October 2003
Issue No. 11

 

IN THIS ISSUE...

Highlights from the 8th International Conference on Orangic Process Research & Development, Barcelona, Spain, 7 -10 September 2003

Efficient Synthesis of the Kappa-Opiod Receptor Antagonist CH-15,161

Process Aspects of Asymmetric Hydrogenation

Process Development of Cryptophycins: Journey Toward Symplicity

New Concepts in Molecular Synthesis:Cascade Catalysis and Multi-Step Conversions in Concert

Lu 02-030: Developing a scalable and viable route to manufacture the drug candidate 4,5,6,7-tetrahydroisoxazolo[5,4-9c]pyridin-3-ol, hydrochloride (THIP)

Ceramide II. From Sample to Process

Radical Transformations in the Macrolide Series: Challenges for Process R & D

Development and Scale-up of Synthetic Routes to AR-C123196

The Chemical Development of a Selective Alpha-Blocker, UK-338,003

Homogeneous Catalysis: From Coors to Heineken

Highlights from the Development of Processes for the Synthesis of 2,6-Diaminopurine Nucleosides

Synthesis, Scale-up and Use of a New Class of Halex Catalysis

From Naproxen to Gabapentin: Twenty Years of Development of Scaleable Routes for Active Ingredients in Zambon

DioRaSSP: Diosynth Rapid Solution Synthesis of Peptides

A Practical Synthesis and Process for the Production of a New HIV Protease Inhibitor

Dihydro-7-benzofurancarboxylic Acid, An Intermediate in the Synthesis of the Enterokinetic Agent R 108512

Creativity Through Diversity in Process Development

Rapid Scale-Up of the Matrix Metalloproteinase Inhibitor CH5902: Process Safety and Route Development Considerations

View, Print or Download the PDF version of the Process Chemistry Newsletter.

WWW.SCIENTIFICUPDATE.CO.UK